Effect of Medication Co-payment Vouchers on P2Y(12) Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial

IMPORTANCE: Despite guideline recommendations, many patients discontinue P2Y(12) inhibitor therapy earlier than the recommended 1 year after myocardial infarction (MI), and higher-potency P2Y(12) inhibitors are underutilized. Cost is frequently cited as an explanation for both of these observations....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA
Main Authors: Wang, Tracy Y., Kaltenbach, Lisa A., Cannon, Christopher P., Fonarow, Gregg C., Choudhry, Niteesh K., Henry, Timothy D., Cohen, David J., Bhandary, Durgesh, Khan, Naeem D., Anstrom, Kevin J., Peterson, Eric D.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2019
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583585/
https://ncbi.nlm.nih.gov/pubmed/30620370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.19791
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares